Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,606 public trials 547 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

NCT02129582

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +44 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Daratumumab for the Treatment of Patients With AL Amyloidosis

NCT02841033

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

NCT02918695

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: ZNA Antwerpen Antwerp, Belgium

Centre Hospitalier EpiCURA Baudour, Belgium

Imelda Ziekenhuis Bonheiden, Belgium

AZ Klina Brasschaat, Belgium

View all 20 locations

View Trial Details

Completed

Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia

NCT01046006

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece

Laikon Hospital Athens, Attica, Greece

Erasmus Medical Center Rotterdam, Netherlands

Hospital Universitario de Salamanca Salamanca, Spain

View Trial Details

Completed

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

NCT00981708

Conditions: Amyloidosis, Disease Attributes, Immune System Diseases, +13 more
Locations: Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece

View Trial Details

Completed

Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma

NCT01177735

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States

View Trial Details

Completed

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

NCT02104427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Stony Brook University Hospital Stony Brook, New York, United States

Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

NCT01458288

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Stony Brook University Hospital Stony Brook, New York, United States

View Trial Details

Completed

A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis

NCT02545907

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
Locations: Derriford Hospital Plymouth, Devon, United Kingdom

Royal Bournemouth General Hospital Bournemouth, Dorset, United Kingdom

Guy's Hospital London, Greater London, United Kingdom

Manchester Royal Infirmary Manchester, Greater Manchester, United Kingdom

View all 14 locations

View Trial Details

Completed

Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM

NCT02112175

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Centre Hospitalier EpiCURA - Clinique Louis Caty de Baudour Baudour, Belgium

AZ-VUB Brussels, Belgium

Grand Hopital de Charleroi Charleroi, Belgium

Universitair Ziehenhuis Antwerpen Edegem, Belgium

View all 73 locations

View Trial Details